R1128 substances are anthraquinone natural products, which were previously reported as nonsteroidal estrogen receptor antagonists with in vitro and in vivo potency approaching that of tamoxifen. From a biosynthetic viewpoint these polyketides possess structurally interesting features, such as an unusual primer unit, that are absent in more well-studied anthracyclic and tetracyclic natural products. The entire R1128 gene cluster was cloned and expressed in Streptomyces lividans, a genetically well-developed heterologous host. In addition to R1128C, a novel optically active natural product, designated HU235, was isolated. Nucleotide sequence analysis of the biosynthetic gene cluster revealed genes encoding two ketosynthases, a chain length factor, an acyl transferase, three acetyl-CoA carboxylase subunits, two cyclases, two oxygenases, an amidase, and remarkably, two acyl carrier proteins. Feeding studies indicate that the unusual 4-methylvaleryl side chain of R1128C is derived from valine. Together with the absence of a dedicated ketoreductase, dehydratase, or enoylreductase within the R1128 gene cluster, this suggests a functional link between fatty acid biosynthesis and R1128 biosynthesis in the engineered host. Specifically, we propose that the R1128 synthase recruits four subunits from the endogenous fatty acid synthase during the biosynthesis of this family of this pharmacologically significant family of natural products.
INTRODUCTION
Non-steroidal estrogen receptor (ER) antagonists such as tamoxifen are the first choice of anti-hormone treatment for breast cancer. However, ER antagonists have variable effects in different target tissues. For example, tamoxifen is an ER antagonist in breast tissue but an ER agonist in bone (1) and uterine (2) tissue. Raloxifene is also an ER antagonist in breast tissue; however, it exerts agonist activity in bone but not uterine tissue. less than that of tamoxifen, their selectivity (50-fold better binding to ER as compared to the androgen receptor) and low toxicity (significant inhibition of tumor volume in a subrenal capsule assay at 100 mg/kg; no acute toxicity in mice or rats at 500 mg/kg) profiles were promising. (7) Thus, the development of rational approaches to manipulate the structures of these natural products offers an opportunity to optimize their pharmacological properties. As a first step in this direction, we describe the cloning and nucleotide sequence of the R1128 biosynthetic gene cluster, and its expression in a model heterologous host, Streptomyces lividans K4-114. (8) We also present evidence that highlights an unusual mechanism for priming this polyketide synthase. 
MATERIALS AND METHODS

Construction of Cosmid Vector pHU204: SCP2* is a widely used low-copy vector for
Streptomyces spp. (9) Although cosmid derivatives of SCP2* have been described earlier (10) , their ability to replicate in Streptomyces spp. in a stable manner has not been tested. Plasmid pHU204 (Fig. 2) is a derivative of pRM5. (11) To make it suitable for library construction, a series of cloning steps were used to replace the 10. were collected, dried, and analyzed.
For the preparation of 13 C-labeled polyketides, cultures were grown on R2YE agar medium supplemented with 500 mg/L 13 C 2 -sodium acetate for 7 days. Products were isolated as described above. Enrichment levels of 0.6% were observed. Cloning and Heterologous Expression of the R1128 Gene Cluster: Anticipating that the R1128 gene cluster was under 40 kb in size, a cosmid library was constructed in pHU204 using genomic DNA derived from Streptomyces sp R1128, the R1128 producer. The entire library was transformed without prior screening into S. lividans K4-114. Several pigmented colonies were identified; one of them, K4-114/pHU235 was cultivated on a larger scale (500 mL on semi-solid R5 agar medium). After neutral extraction and pre-purification using column chromatography, two major UV-active peaks were collected from reverse-phase HPLC, dried, and analyzed. Mass-, 1 H and 13 C NMR spectra revealed that one of the compounds was identical to R1128C. The purified yield of the compound was 1 mg/L. The second compound, designated Since the carbon chain backbone of HU235 is identical to that of R1128C, the polyketide origin of this product was established by feeding of 1,2-13 C sodium acetate (Fig. 3) . The carbon skeleton comprised of C-2 to C-14 was labeled as expected. (C-1 is eliminated via decarboxylation.) Interestingly, the incorporation efficiency of labeled acetate into the C-15 -C-16 multi-carbon unit was comparable to that in the remaining multi-carbon units of HU235, suggesting that the 4-methylvaleryl moiety is contemporaneously synthesized with the rest of the polyketide skeleton. If so, this raises the question as to the mechanism of reduction of the C-17 carbon atom (discussed below).
RESULTS
Construction of a New Cosmid Shuttle Vector for
Nucleotide Sequence Analysis of the Biosynthetic Gene Cluster: Cosmid pHU235
was initially sequenced to ca. 3-4X coverage using a shotgun approach. Based on this data a 17 kb region of the cosmid was identified that appeared to contain all the biosynthetic genes; accurate sequence of this region was obtained through a combination of sub-cloning and oligonucleotide walking. The results of sequence analysis of this segment of pHU235 are graphically presented in Figure 4 and summarized in Table 1 . In addition to the above biosynthetic enzymes, the R1128 gene cluster also encodes two other unusual enzymes. First, it contains a homolog (zhuL) of a class of known amidases, such as an enantioselective amidase from a Rhodococcus strain that hydrolyzes 2-arylpropionamides.
(25) The role of ZhuL in R1128 biosynthesis is unclear, but this family of amidases also shares similarity to the GatA subunit of glutamyl-tRNA(Gln) amidotransferases (e.g. the Deinococcus radiodurans enzyme (26)) which is responsible for amide hydrolysis as well as transfer of the resulting amine to glutamyl-tRNA. Perhaps the conserved aminotransferase activity in ZhuL allows it to function as a valine deaminase, an enzyme that is predicted to be involved in conversion of valine into isobutyryl-CoA required for R1128C biosynthesis (see below).
Second, the gene cluster encodes three polypeptides, ZhuD, ZhuE, and ZhuF, that are homologous to acetyl-CoA carboxylase subunits. ZhuD is predicted to be a biotin carboxylase, ZhuE is predicted to be a biotin carboxyl carrier protein, whereas ZhuF is homologous to carboxyl transferase subunits. Recent studies on jadomycin biosynthesis have revealed the presence of zhuD and zhuE homologs (but not a zhuF homolog) in the jadomycin gene cluster.
(27) Genetic inactivation of these subunits leads to significant reduction in jadomycin biosynthesis, underscoring the role of this multi-subunit enzyme in the biosynthesis of malonylCoA precursors for polyketide biosynthesis.
Perhaps the most interesting feature of the R1128 gene cluster is the presence of not one but two ACP genes. This feature is absent in biochemically characterized PKS pathways such as actinorhodin (28) or daunorubicin (29,30), but is present in the frenolicin PKS (31) (see also GenBank accession # AAC18105). As in R1128A, the frenolicin polyketide backbone is presumably derived by transfer of a butyryl unit on to the KS-CLF heterodimer (32) . The mechanistic implications of a dual-ACP aromatic PKS system are discussed below. We simply note here that ZhuN is more similar to FrnN (58% identity with FrnN versus 40% identity with FrnJ) (31), whereas ZhuG is more similar to FrnJ (46% identity with FrnJ versus 40% identity with FrnN) (GenBank accession # AAC18105). Table 2 .
Although overall production levels are lower in SMM medium than in R2YE medium (reported above), productivity is dramatically enhanced upon valine supplementation, confirming that the 4-methylvaleryl moiety of R1128C is derived from valine. Oxidation of valine to yield isobutyryl-CoA is known to involve elimination of the carboxy group as carbon dioxide. (33) Consistent with this notion, 1-13 C-valine did not result in enhancement of any peak in the 13 C-NMR spectrum of HU235. In most cases the minimal PKS defined above is primed via decarboxylation of a malonyl unit to yield an acetyl-S-KS intermediate that is subsequently elongated. However, some bacterial aromatic PKSs are primed by alternative primer units. For example, daunorubicin is derived from a propionyl primer unit. Such systems possess two additional PKS components-a priming KS dedicated solely to the first condensation cycle, and an acyltransferase. In the daunorubicin PKS these proteins are responsible for converting malonyl-S-ACP into β-ketopentanoyl-S-ACP, which is subsequently transferred onto the active site of the KS-CLF of the minimal PKS. By analogy, ZhuC, ZhuH, and malonated ZhuG produce either an acetoacetyl-S-ACP, β-ketopentanoyl-S-ACP, or 2-oxo-4-methyl-pentanoyl-S-ACP (Fig. 5) . However, unlike the daunorubicin example, these ACP-bound intermediates must be reduced into butyryl-S-ACP, valeryl-S-ACP, or 4-methylvaleryl-S-ACP, respectively, before transfer to the KS-CLF heterodimer. A similar situation is also encountered in the context of bacterial fatty acid biosynthesis (36) , where FabH (a ZhuH homolog) catalyzes the first chain extension step, followed by the successive action of a ketoreductase, a dehydratase, and an enoylreductase to reduce the β-ketothioester. Since homologs of the ketoreductase, dehydratase, and enoylreductase are absent from the R1128 gene cluster, we anticipate that the R1128 synthase recruits these enzymes from the endogenous fatty acid synthase (Fig. 5) . This is analogous to the well-established recruitment of the MAT by the minimal PKS (20) , and may also occur in the case of frenolicin biosynthesis, as suggested by the DNA sequence of the gene cluster and the structure of the polyketide product. Perhaps this explains the need for two ACPs rather than one in systems that interact with two different sets of ketosynthases, acyltransferases, and auxiliary enzymes. If so, then this sub-class of PKSs might present an attractive model system for studying the role of ACP mediated protein-protein interactions in multi-enzyme assemblies. (37) Moreover, it would represent yet another example of physiological crosstalk between polyketide and fatty acid biosynthesis, as originally proposed in the context of actinorhodin biosynthesis in Streptomyces coelicolor. (38) Upon synthesis of the full-length polyketide chain through the action of ZhuA, ZhuB, ZhuC, ZhuG, ZhuH, ZhuN, and four components of the fatty acid synthase, this highly reactive intermediate must undergo controlled cyclization and oxidation into the R1128 series of products.
The first regiocontrolled cyclization occurs via an aldol condensation between the C-7 carbonyl atom and the acidic C-12 methylene atom of the nascent polyketide chain, and is followed by enolization and the elimination of a water molecule to generate an aromatic ring system. These reactions are presumably catalyzed by the ZhuI aromatase/cyclase (Fig. 5) . Both monodomain and didomain members of this protein family are known. (39) Didomain orthologs are encountered in PKSs that produce compounds in which the C-9 carbonyl undergoes reduction, whereas monodomain subunits are involved in the biosynthesis of unreduced polyketides. The fact that ZhuI is a monodomain protein is consistent with the lack or reduction of the C-9 carbonyl atom.
The second aldol condensation between C-5 and C-14 is presumably catalyzed by ZhuJ, whose homologs include DpsY from the daunorubicin pathway (Fig. 5) . Once this bicyclic aromatic system is formed, two fates are possible (Fig. 5) . On one hand the intermediate can undergo cyclization between C-2 and C-15, followed by C-6 oxygenation and decarboxylation, to afford the R1128 series of compounds. On the other hand, decarboxylative elimination of C-1, followed by cyclization between C-3 and C-16 can yield the novel compound HU235 reported
here. The precise sequence of reactions in either path cannot be predicted, although ZhuK and/or
ZhuM are presumably involved in the pathway to R1128. It might therefore be suspected that HU235 is a shunt product due to inadequate activity of these enzymes in vivo. However, the optical activity of HU235 suggests an enzymatic route for this unusual metabolite. Further studies will be required to decipher the biochemical course of these divergent pathways. Fig. 1 . Structures of the R1128 compounds. 
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